MOSCOW (MRC) -- AkzoNobel and Evonik Industries have joined forces to build and operate a new membrane electrolysis facility for potassium hydroxide solution and chlorine in Germany, the companies announced in the press-releases.
Start-up is expected by the end of 2017.
The 50-50 joint venture involves the construction and operation of a dedicated plant at AkzoNobel's existing site in Ibbenburen. It will have an annual nameplate capacity of around 130,000 tons of potassium hydroxide solution and 82,000 tons of chlorine. This will strengthen the leading market positions of both companies, according to project officials.
Financial details were not disclosed.
AkzoNobel will take over commercialization of chlorine and hydrogen at the new plant, and will process these products directly at the Ibbenburen site. Evonik will take over the potassium hydroxide solution for commercialization and processing at its own site in Lulsdorf. This is where Evonik processes potassium hydroxide solution into potassium carbonate (potash).
All production of chlorine, potassium hydroxide and caustic lye using mercury-based amalgam electrolysis has to stop by the end of 2017 due to legislative requirements. The planned new membrane electrolysis plant will use a sustainable process which has a more positive environmental profile.
As MRC informed earlier, both companies entered into negotiations to build a membrane electrolysis facility at AkzoNobel's site in Ibbenburen (Germany) in July 2014.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world.
Akzo Nobel N.V., trading as AkzoNobel, is a Dutch multinational, active in the fields of decorative paints, performance coatings and specialty chemicals. Headquartered in Amsterdam, the company has activities in more than 80 countries, and employs approximately 55,000 people.
MRC